« Back to Record
Citation APA

Psyrri, A., Remenar, E., Degardin, M., Pateras, I. I., Langendijk, J. J., van Herpen, C. C., Awada, A., Germa, J. R. L. J., Kienzer, H. R., Licitra, L., Vermorken, J. B., Fortpied, C., Koutsodontis, G., Avgeris, M., Kroupis, C., Goutas, N., Menis, J., Herman, L., & Giurgea, L. (2017). Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study. Annals of oncology, 28(9), 2213-2218. doi:10.1093/annonc/mdx320


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/260124

Psyrri, A., Remenar, E., Degardin, M., Pateras, I. I., Langendijk, J. J., van Herpen, C. C., Awada, A., Germa, J. R. L. J., Kienzer, H. R., Licitra, L., Vermorken, J. B., Fortpied, C., Koutsodontis, G., Avgeris, M., Kroupis, C., Goutas, N., Menis, J., Herman, L., & Giurgea, L. (2017). Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study. Annals of oncology, 28(9), 2213-2218. doi:10.1093/annonc/mdx320